Literature DB >> 2010556

Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates.

R H Gundel1, L G Letts, G J Gleich.   

Abstract

We have examined the effects of direct intratracheal instillation of purified eosinophil granule proteins on pulmonary function and airway responsiveness in primates. The results of this study show for the first time that installation of major basic protein (MBP) directly into the trachea of primates results in a significant and dose-related increase in airway responsiveness to inhaled methacholine. Furthermore, MBP and eosinophil peroxidase (EPO) induce a transient bronchoconstriction immediately after instillation that resolves by 1 h postinstillation. In contrast, instillation of other eosinophil granule proteins had no effect on airway responsiveness or pulmonary function. These data indicate a direct role of the eosinophil in the pathogenesis of airway hyperresponsiveness. We suggest that the MBP of human eosinophils has an effector role in the pathogenesis of airway hyperresponsiveness which may involve active interaction with resident airway tissue cells. MBP may also mediate altered lung function in various inflammatory lung diseases associated with pulmonary eosinophilia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010556      PMCID: PMC295201          DOI: 10.1172/JCI115155

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Indomethacin and FPL-57231 inhibit antigen-induced airway hyperresponsiveness in sheep.

Authors:  S Lanes; J S Stevenson; E Codias; A Hernandez; M W Sielczak; A Wanner; W M Abraham
Journal:  J Appl Physiol (1985)       Date:  1986-09

2.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

3.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.

Authors:  A J Wardlaw; S Dunnette; G J Gleich; J V Collins; A B Kay
Journal:  Am Rev Respir Dis       Date:  1988-01

4.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

5.  Dynamic respiratory mechanics in monkeys measured by forced oscillations.

Authors:  C D Wegner; A C Jackson; J D Berry; J R Gillespie
Journal:  Respir Physiol       Date:  1984-01

6.  Increases in airway reactivity to histamine and inflammatory cells in bronchoalveolar lavage after the late asthmatic response in an animal model.

Authors:  W R Marsh; C G Irvin; K R Murphy; B L Behrens; G L Larsen
Journal:  Am Rev Respir Dis       Date:  1985-06

7.  Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro.

Authors:  S Motojima; E Frigas; D A Loegering; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1989-03

8.  Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season.

Authors:  O Löwhagen; S Rak
Journal:  J Allergy Clin Immunol       Date:  1985-04       Impact factor: 10.793

9.  Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium.

Authors:  N A Flavahan; N R Slifman; G J Gleich; P M Vanhoutte
Journal:  Am Rev Respir Dis       Date:  1988-09

10.  Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins.

Authors:  L M Zheutlin; S J Ackerman; G J Gleich; L L Thomas
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

View more
  67 in total

1.  Adoptive transfer of allergen-specific CD4+ T cells induces airway inflammation and hyperresponsiveness in brown-Norway rats.

Authors:  A Haczku; P Macary; T J Huang; H Tsukagoshi; P J Barnes; A B Kay; D M Kemeny; K F Chung; R Moqbel
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 2.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

Review 3.  The future of asthma therapy: integrating clinical and experimental studies.

Authors:  David B Corry; Farrah Kheradmand
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 5.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis.

Authors:  Seema S Aceves; Steven J Ackerman
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

6.  An essential role for interleukin-5 and eosinophils in helminth-induced airway hyperresponsiveness.

Authors:  L R Hall; R K Mehlotra; A W Higgins; M A Haxhiu; E Pearlman
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Effects of phosphodiesterase isoenzyme inhibitors on cutaneous inflammation in the guinea-pig.

Authors:  M M Teixeira; A G Rossi; T J Williams; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

8.  Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.

Authors:  A J Coyle; S J Ackerman; R Burch; D Proud; C G Irvin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 9.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

Review 10.  Re-defining the unique roles for eosinophils in allergic respiratory inflammation.

Authors:  E A Jacobsen; N A Lee; J J Lee
Journal:  Clin Exp Allergy       Date:  2014-09       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.